JP2003535862A - 糖尿病の治療のためのチアゾリジンジオン塩 - Google Patents

糖尿病の治療のためのチアゾリジンジオン塩

Info

Publication number
JP2003535862A
JP2003535862A JP2002501893A JP2002501893A JP2003535862A JP 2003535862 A JP2003535862 A JP 2003535862A JP 2002501893 A JP2002501893 A JP 2002501893A JP 2002501893 A JP2002501893 A JP 2002501893A JP 2003535862 A JP2003535862 A JP 2003535862A
Authority
JP
Japan
Prior art keywords
hydrobromide
solvate
thiazolidine
pyridyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002501893A
Other languages
English (en)
Japanese (ja)
Inventor
アンドリュー・サイモン・クレイグ
ティム・チーン・ティン・ホ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of JP2003535862A publication Critical patent/JP2003535862A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
JP2002501893A 2000-06-08 2001-06-08 糖尿病の治療のためのチアゾリジンジオン塩 Pending JP2003535862A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
GB0014006.1 2000-06-08
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
JP2003535862A true JP2003535862A (ja) 2003-12-02

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002501893A Pending JP2003535862A (ja) 2000-06-08 2001-06-08 糖尿病の治療のためのチアゾリジンジオン塩

Country Status (23)

Country Link
EP (1) EP1296980A1 (no)
JP (1) JP2003535862A (no)
KR (1) KR20030007918A (no)
CN (1) CN1443186A (no)
AP (1) AP2002002673A0 (no)
AU (1) AU2001264078A1 (no)
BG (1) BG107357A (no)
BR (1) BR0111536A (no)
CA (1) CA2411065A1 (no)
CZ (1) CZ20023966A3 (no)
DZ (1) DZ3382A1 (no)
EA (1) EA200300005A1 (no)
GB (1) GB0014006D0 (no)
HU (1) HUP0301137A3 (no)
IL (1) IL153279A0 (no)
MA (1) MA25753A1 (no)
MX (1) MXPA02012100A (no)
NO (1) NO20025883L (no)
OA (1) OA12284A (no)
PL (1) PL360592A1 (no)
SK (1) SK17142002A3 (no)
WO (1) WO2001094344A1 (no)
ZA (1) ZA200209954B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010517979A (ja) * 2007-02-06 2010-05-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンズイミダゾール誘導体の製造方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
WO2008091624A2 (en) * 2007-01-22 2008-07-31 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010517979A (ja) * 2007-02-06 2010-05-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンズイミダゾール誘導体の製造方法

Also Published As

Publication number Publication date
GB0014006D0 (en) 2000-08-02
OA12284A (en) 2003-11-10
PL360592A1 (en) 2004-09-20
EA200300005A1 (ru) 2003-04-24
HUP0301137A2 (hu) 2003-08-28
WO2001094344A1 (en) 2001-12-13
IL153279A0 (en) 2003-07-06
HUP0301137A3 (en) 2005-04-28
SK17142002A3 (sk) 2003-10-07
CN1443186A (zh) 2003-09-17
CZ20023966A3 (cs) 2003-04-16
BR0111536A (pt) 2003-07-01
MA25753A1 (fr) 2003-04-01
DZ3382A1 (fr) 2001-12-13
CA2411065A1 (en) 2001-12-13
BG107357A (bg) 2003-08-29
AP2002002673A0 (en) 2002-12-31
MXPA02012100A (es) 2003-04-25
AU2001264078A1 (en) 2001-12-17
KR20030007918A (ko) 2003-01-23
ZA200209954B (en) 2003-10-10
EP1296980A1 (en) 2003-04-02
NO20025883D0 (no) 2002-12-06
NO20025883L (no) 2003-02-03

Similar Documents

Publication Publication Date Title
JP2003527393A (ja) ５−［４−［２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンの塩酸塩
JP2003535862A (ja) 糖尿病の治療のためのチアゾリジンジオン塩
EP1305312B1 (en) Tartrate salts of thiazolidinedione derivative
JP2004508369A (ja) ５−［４−［２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンの塩酸塩
JP2005515987A (ja) ロジグリタゾンエディシレート抗糖尿病剤としてのその使用
KR100755174B1 (ko) 티아졸리딘디온 유도체의 타르타르산염
JP2004508367A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
JP2004508370A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
JP2003535861A (ja) 医薬用の５−（４−（２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ）ベンジル）チアゾリジン−２，４−ジオン・ヨウ化水素酸塩
JP2004505971A (ja) チアゾリジンジオン誘導体の酒石酸塩
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
JP2004509959A (ja) ５−’４−’２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンのナトリウム塩
JP2004509960A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
US20030162815A1 (en) Thiazolidinedione salt for treatment of diabetes mellitus
JP2004508368A (ja) チアゾリジノン硝酸塩
AU2005229694A1 (en) Tartrate salt of thiazolidinedione derivative